Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 820 results for "hcv"

Bristol-Myers Squibb's HCV Drug Daclatasvir Receives CRL

Bristol-Myers Squibb Company ( BMY ) announced that the FDA has issued a complete response letter ( CRL ) for the new drug application (:NDA) for hepatitis C virus (:HCV) candidate, daclatasvir. The company is looking to get daclatasvir approved in ... Yahoo! Finance, 11 hours ago

80 images for hcv

Longford Leader, 1 week ago
Aidsmap, 15 hours ago
Aidsmap, 15 hours ago
KXXV-TV, 2 days ago
MDLinx, 2 days ago
MDLinx, 3 days ago
MDLinx, 3 days ago
MySarawak, 6 days ago
Yahoo! Finance, 1 week ago
Aidsmap, 6 days ago

ABT-450/r/Ombitasvir and Dasabuvir for HCV

Pietro Andreone, Massimo G. Colombo, Jeffrey V. Enejosa, Iftihar Koksal, Peter Ferenci, Andreas Maieron, Beat M├╝llhaupt, Yves Horsmans, Ola Weiland, Henk W. Reesink, Lino Rodrigues Jr., Yiran B. Hu, Thomas Podsadecki, Barry Bernstein ...
 Medscape21 hours ago

Biotech Stock Roundup: BioMarin to Acquire Prosensa, AbbVie HCV Therapy Closer to EU Approval

Once again, deals and collaborations made news in the biotech sector with BioMarin ( BMRN ) announcing its intention to acquire Prosensa ( RNA ) and Five Prime Therapeutics ( FPRX ) signing a second immuno-oncology focused deal with Bristol-Myers ...
 Yahoo! Finance1 day ago

AbbVie's HCV Cocktail Treatment Closer to EU Approval

AbbVie's ( ABBV ) cocktail hepatitis C virus (:HCV) treatment is now closer to EU approval with the European Medicines Agency's ( EMA.TO ) European Committee for Medicinal Products for Human Use ( CHMP ) providing positive opinions regarding the ...
 Yahoo! Finance3 days ago EU recommendation for AbbVie's next-gen hep C treatment  Pharma Field3 days ago

HCV: oral drug

The news carried in your paper of Nov 21 about the availability of an oral drug for the treatment of Hepatitis C virus (HCV) is indeed great news for patients of the disease in Pakistan. The US Federal Department of Agriculture-approved drug will be ...
 DAWN Group2 days ago Gilead announces favorable results from Phase II and Phase III HCV studies  Individual.com1 week ago Gilead announces encouraging data from Phase II HCV infection studies  Individual.com1 week ago Gilead's Sovaldi Effective In Combination For HCV, Studies Find  Bioresearch Online1 week ago

European Ad Comm gives thumbs up to AbbVie's HCV combo

News Editor The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopts a positive opinion supporting approval of AbbVie's (NYSE:ABBV) Viekirax (a combination of ombitasvir, paritaprevir and ritonavir) plus Exviera ...
 Seeking Alpha6 days ago AbbVie Gets Positive CHMP Opinion For VIEKIRAX + EXVIERA To Treat HCV  RTTNews.com6 days ago EMA panel recommends approval of DAA regimen for patients with HCV  Orthopedics Today6 days ago AbbVie Nabs Positive Opinions For VIEKIRAX Plus EXVIERA To Treat HCV  BioSpace6 days ago

Turbocharger Market by Vehicle Type (Passenger Car, LCV & HCV), Fuel Type (Diesel & Gasoline), Technology (VGT/VNT, Wastegate & Twin-Turbo), & Region - Industry Trends & Forecasts to 2019

From the Wires Nov. 25, 2014 03:24 PM LONDON , Nov. 25, 2014 /PRNewswire/ -- The biggest challenge faced by the global automotive industry is meeting the regulations and standards set regarding the emissions of exhaust gases such as Carbon ...
 Sys-Con India2 days ago Automotive Steering Systems Market by Vehicle Type (Passenger Car, LCV, & HCV), System Type (Manual, HPS, EHPS & EPS), Safety Features (With ABS/ESP & Without ABS/ESP), & Geography - Industry Trends &  WorldNetDaily1 week ago

Gilead's once daily tablet regimen, Harvoni gets European marketing nod to treat HCV with genotype 1 & 4

The European Commission has granted marketing authorization for Gilead Sciences' Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg), the first once-daily single tablet regimen to treat the majority of chronic hepatitis C genotype 1 and 4 infection in ...
 PharmaBiz1 week ago Gilead gets Harvoni boost for Europe  Pharmafocus1 week ago First all-oral hepatitis C regimen approved  Pharmacist.com11 hours ago Gilead Sciences : European Commission Grants Marketing Authorization for Gilead's Harvoni┬«? Ledipasvir/Sofosbuvir, the First Single Tablet Regimen to Treat the...  4 Traders1 day ago

Herbal Remedy Shows Early Promise as HCV Prophylaxis

Reuters Health Information By David Douglas November21,2014 NEW YORK (Reuters Health) - Saikosaponin b2 (SSb2) extracted from Bupleurum kaoi root, a traditional liver disease remedy, can block hepatitis C virus (HCV) entry into cells, according ...
 Medscape6 days ago

Gilead Gains on Harvoni's EU Approval for HCV Treatment

Shares of Gilead Sciences Inc. ( GILD ) were up 3.3% after the company announced that its hepatitis C virus (:HCV) drug, Harvoni, gained approval from the European Commission for treating adults suffering from chronic hepatitis C genotype 1 and 4 ...
 Yahoo! Finance1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hcv
Get updated on latest news & your favorite topics right in your inbox!
More     Less